(Q45236677)

11 December 2017

title

Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma (English)

1 reference

11 December 2017

1 reference

1 reference

S Thongprasert

1

1 reference

11 December 2017

S Napapan

series ordinal

2

1 reference

11 December 2017

C Charoentum

series ordinal

3

1 reference

11 December 2017

S Moonprakan

series ordinal

4

1 reference

11 December 2017

language of work or name

1 reference

1 February 2005

1 reference

11 December 2017

1 reference

11 December 2017

volume

16

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

279-281

1 reference

Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI046

Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI046

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI046

Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI046

Chemotherapy with gemcitabine in patients with advanced gallbladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI046

Phase II Trial of the Use of Gemcitabine and 5-Fluorouracil in the Treatment of Advanced Pancreatic and Biliary Tract Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI046

Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI046

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI046

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI046

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDI046

1 reference

release_mffvgukekng6fjqgbudxnvy52u

11 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mffvgukekng6fjqgbudxnvy52u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference